Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

GREM1 is required to maintain cellular heterogeneity in pancreatic cancer

29 Jun 2022

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Cells and Metastasis
Share to Pancreatic and Hepatic Oncology Research
Share to TGF-β signaling in diseases

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 35768509
DOI: 10.1038/s41586-022-04888-7

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

GREM1 is required to maintain cellular heterogeneity in pancreatic cancerPMID 35768509Read ↗

Current status and prospects of GREM1 research in cancer (Review)Semantic proximity Read ↗

Molecular alterations contributing to pancreatic cancer chemoresistanceSemantic proximity Read ↗

Genome-wide aberrations in pancreatic adenocarcinomaSemantic proximity Read ↗

Single-cell mapping identifies MSI+ cells as a common origin for diverse subtypes of pancreatic cancerSemantic proximity Read ↗

Phenotypic, Genomic, and Transcriptomic Heterogeneity in a Pancreatic Cancer Cell Line.Semantic proximity Read ↗

Integration of transcriptome and cistrome analysis identifies RUNX1-target genes involved in pancreatic cancer proliferationSemantic proximity Read ↗

BLIMP1 Induces Transient Metastatic Heterogeneity in Pancreatic CancerSemantic proximity Read ↗

HELLS serves as a poor prognostic biomarker and its downregulation reserves the malignant phenotype in pancreatic cancer.Semantic proximity Read ↗

HRD1 in human malignant neoplasms: Molecular mechanisms and novel therapeutic strategy for cancerSemantic proximity Read ↗

A unifying paradigm for transcriptional heterogeneity and squamous features in pancreatic ductal adenocarcinomaSemantic proximity Read ↗

Pan-Cancer analysis and experimental validation identify the oncogenic nature of ESPL1: Potential therapeutic target in colorectal cancerSemantic proximity Read ↗

Pre-existing Functional Heterogeneity of Tumorigenic Compartment as the Origin of Chemoresistance in Pancreatic TumorsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.